Global Seasonal Influenza Market, By Type (Influenza A Viruses, Influenza B Viruses, Influenza C Virus, Influenza D Viruses, Others), Treatment (Antiviral, Neuraminidase Inhibitors, Vaccination, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Seasonal Influenza Market Analysis and Size
The global seasonal influenza market is expected to witness significant growth during the forecast period. Wide availability of diagnostic tests & increased advancement in the treatment of seasonal influenza, minimum side effects with the vaccination will also boost up the seasonal influenza market. Furthermore, varied advances in the treatment options and the existence of well-established healthcare facilities are some of the major impacting factors for the demand of the market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global seasonal influenza market in the forecast period 2022-2029. The expected CAGR of global seasonal influenza market is tend to be around 20% in the mentioned forecast period. The market was valued at USD 6.5 billion in 2021, and it would grow upto USD 27.95 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Seasonal influenza is the type of acute respiratory infection that is caused by the influenza virus. Symptoms include sudden onset of fever, headache, muscle and joint pain, fatigue, sore throat and runny nose. Pregnant women, children under 59 months or under 5 years, elderly population and people with chronic diseases are prone to seasonal influenza.
Seasonal Influenza Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Influenza A Viruses, Influenza B Viruses, Influenza C Virus, Influenza D Viruses, Others), Treatment (Antiviral, Neuraminidase Inhibitors, Vaccination, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), SHIONOGI & Co., Ltd (Japan), SINOVAC (China)
|
|
Market Opportunities
|
|
Global Seasonal Influenza Market Dynamics
Drivers
- Rising Prevalence of Influenza
It was witnessed during the 2020-2021 flu season, there was very low prevalence of seasonal flu viruses. During the phase from September 27, 2020–May 22, 2021 in the U.S, around 1,899 of 1,081,671 clinical samples tested were positive for an influenza virus. This boosts the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Demand for Retail Pharmacies
The rise in the number of influenza therapeutics delivered through the retail pharmacies and the increase in the number of retail pharmacies in highly developing countries can create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Rising Awareness
In the last few years, government and non-government organizations in developing countries, have taken extreme efforts to raise awareness for preventive medicine. Several programs are conducted that reach out to uneducated people especially in rural areas. This is a key factor that boosts the seasonal influenza market in the world's emerging economies.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global seasonal influenza market over a forecast period.
- Side Effects of Vaccines For Influenza
Vaccines have many side effects that surely hamper the market growth. Side effects such as fever, chills, enduration, pain and soreness, and many such effects restrain the growth of the market.
This global seasonal influenza market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global seasonal influenza market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Seasonal Influenza Market Scope
The global seasonal influenza market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Influenza A Viruses
- Influenza B Viruses
- Influenza C Virus
- Influenza D Viruses
- Others
Treatment
- Antiviral
- Neuraminidase Inhibitors
- Vaccination
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Seasonal Influenza Market Regional Analysis/Insights
The global seasonal influenza market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global seasonal influenza market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global seasonal influenza market throughout the forecasted period due to the presence of key manufacture of the product, high R & D and healthcare expenditure with skilled professionals.
Asia-Pacific dominates the market due to increased government awareness programs and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Seasonal Influenza Market Share Analysis
The global seasonal influenza market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global seasonal influenza market.
Key players operating in the global seasonal influenza market include:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- SHIONOGI & Co., Ltd (Japan)
- SINOVAC (China)
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key
SKU-